“merck” Archives

in
Entry Author Date Location
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Merck, Amgen Invest in Akili as Therapeutic Video Game Moves Ahead 07/20/16 Boston
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs 07/19/16 Boston
As Purdue Pushes Life Sciences, Foundation Seeks $10M For New Fund 07/18/16 Indiana
Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News 07/15/16 National
Tesaro Stock Sale Hauls in $409M on Heels of Strong Cancer Data 07/08/16 Boston
With CF Pact, Moderna and Vertex Aim to Spray mRNA Into the Lungs 07/06/16 Boston
Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More 07/01/16 National
Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact 06/29/16 Boston
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Pharma, Data Veteran Stephen Friend Bites At Apple’s Health Offer 06/23/16 Seattle
Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 06/17/16 National
Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle 06/16/16 Boston
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Exit Interview: Lita Nelsen on MIT Tech Transfer, Startups & Culture 05/31/16 Boston
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
Gerngross Mulls Buying Back GlycoFi After Merck Closes HQ 05/17/16 Boston
Pressured by a Lender, Bind Files for Bankruptcy 05/02/16 Boston
Elanco Gets FDA Nod on Biological Drug for Dairy Cows 04/12/16 Indiana
Emulate Gets $28M to Roll Out “Plug and Play” Organ-on-Chip Tech 03/28/16 Boston
West Coast Bio Roundup: Gilead, Affymetrix, Acutus, Frazier & More 03/25/16 San Diego
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
Tech Megatransfer: Merck Pays Harvard $20M For “Accelerated” Cancer Drugs 03/21/16 Boston
West Coast Bio Roundup: UCLA Cashes In, BioMarin Tries Again & More 03/04/16 San Francisco
Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer 03/03/16 Boston
Syndax Cuts Price But Bags $53M in Second IPO Try 03/02/16 Boston
East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More 02/05/16 Boston
Improving Odds for Women in Tech? Take Notes from Biotech 02/04/16 Boston
Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs 02/02/16 Boston
Page 2 of 20 « previous page · next page »